Quark Pharmaceuticals

Pioneering genetic advancements for a healthier future through innovative technology and impactful collaborations.

General Information
Company Name
Quark Pharmaceuticals
Founded Year
1994
Location (Offices)
Founders / Decision Makers
Number of Employees
9
Industries
Biotechnology
Funding Stage
Series Unknown
Social Media

Quark Pharmaceuticals - Company Profile

Quark Pharmaceuticals is a biotechnology company that has been making waves since its establishment in 1994. The company has focused on developing the BiFAR technology platform for identifying new functional target genes and proteins. This innovative approach, patented by Quark, involves high-throughput gene inactivation combined with microarray detection of the functional genes responsible for phenotypes of interest. This groundbreaking technique has been instrumental in advancing gene discovery programs targeting serious diseases with significant unmet medical needs. With the rise of siRNA technology, Quark's approach is gaining traction and is rapidly becoming the preferred method for functional studies across the industry. The company has forged impactful collaborations with large pharmaceutical partners to utilize the BiFAR platform in driving genetic advancements. Notably, Quark secured a $10.00M Venture Round investment on 01 June 2010, which underscores the confidence investors have in the company's technology and potential impact. Through their pioneering efforts and innovative technology, Quark is dedicated to shaping a healthier future and addressing unmet medical needs in the field of genetics.

Taxonomy: genetic advancements, technology platform, BiFAR technology, siRNA technology, gene discovery, functional studies, pharmaceutical collaborations, innovation, high-throughput gene inactivation, microarray detection, targeted gene identification, disease research, medical innovation, startup success

Funding Rounds & Investors of Quark Pharmaceuticals (5)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $10.00M - 01 Jun 2010
Venture Round $27.00M 1 04 Jul 2008
Series H $13.90M 2 Tako Ventures 18 Apr 2008
Series G $10.50M 1 Tako Ventures 01 Jan 2006
Series F Unknown - 11 Sep 2001

Latest News of Quark Pharmaceuticals

View All

No recent news or press coverage available for Quark Pharmaceuticals.

Similar Companies to Quark Pharmaceuticals

View All
Agrisoma Biosciences - Similar company to Quark Pharmaceuticals
Agrisoma Biosciences Pioneering new biofuel crops through advanced genetic technology for the bio-energy market.
Remedium Bio - Similar company to Quark Pharmaceuticals
Remedium Bio We believe that any disease can be cured
Benitec Biopharma Inc. - Similar company to Quark Pharmaceuticals
Benitec Biopharma Inc. Silencing genes for life
Bitrobius Genetics - Similar company to Quark Pharmaceuticals
Bitrobius Genetics Developing the Gentrafix platform technology to revolutionise gene therapy.